The latest oncology treatment & supportive care news
How gut bacteria change cancer drug activity
The activity of cancer drugs changes depending on the types of microbes living in the…
Browsing: Treatment and Support
Identifying why immunotherapy fails in some patients
Our immune system has an army of cells comprised of macrophages, T lymphocytes and natural…
Second cancers deadlier in young patients
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they…
Growing body of evidence supports use of mind-body therapies in breast cancer treatment
In newly updated clinical guidelines from the Society for Integrative Oncology (SIO), researchers at Columbia…
Research shows surgery adds years for kidney cancer patients
Mayo Clinic researchers have discovered that surgery could more than double life expectancy for many…
T cell revival correlates with lung cancer response to PD-1 immunotherapy
In lung cancer patients who were taking immunotherapy drugs targeting the PD-1 pathway, testing for…
SIRT better tolerated than sorafenib, but doesn’t increase overall survival in HCC
Results of the SARAH trial presented today demonstrate that SIRT resulted in median overall survival…
Nivolumab produces durable responses & long-term survival in severe liver cancer patients
Results from the CheckMate 040 study found that nivolumab, an immuno-oncology drug which acts by…
Scientists identify new way of attacking breast cancer
Scientists have discovered a brand new way of attacking breast cancer that could lead to…
New blood test offers potential for faster, targeted treatment of non-small-cell lung cancer
Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians…